14Oct 2024
ANGPTL4/8 and CD-ANGPTL4 Linked to Cardiovascular Risk

ANGPTL4/8 and CD-ANGPTL4 Linked to Cardiovascular Risk

ANGPTL4/8 and CD-ANGPTL4 were significantly associated with diabetes, inflammation, and cardiovascular mortality in both the LURIC and getABI cohorts. Hazard ratios for cardiovascular mortality were notably elevated for the highest tertiles of ANGPTL4/8 (1.47-1.68) and CD-ANGPTL4 (2.44-2.76) compared to the lowest. Conversely, ANGPTL3/8, which inhibits GPIHBP1-LPL activity and is linked to increased LDL-C and triglyceride levels, did not correlate with cardiovascular death. These findings highlight the potential role of ANGPTL4/8 and CD-ANGPTL4 as biomarkers for cardiovascular risk and metabolic disorders, offering new insights into lipid metabolism and inflammation-related pathways.

  • #cardiology

Like

Save

Share